Abstract
Nanotechnology-based approaches have tremendous potential for enhancing efficacy against infectious diseases. PLGA-based nanoparticles as drug delivery carrier have shown promising potential, owing to their sizes and related unique properties. This article aims to develop nanosized poly (d, l-lactide-co-glycolide) PLGA nanoparticle formulation loaded with quercetin (QT). QT is an antioxidant and antibacterial compound isolated from Chinese traditional medicine with low skin permeability and extreme water insolubility. The quercetin-loaded PLGA nanoparticles (PQTs) were synthesized by emulsion–solvent evaporation method and stabilized by coating with poly (vinyl alcohol). The characteristics of PQTs were analyzed by Fourier transform infrared spectroscopy, Ultraviolet–Visible spectroscopy, scanning electron microscope, transmission electron microscopy, and atomic force microscopy, respectively. The PQTs showed a spherical shape with an average size of 100–150 nm. We compared the antibacterial effects of PQTs against Escherichia coli (E. coli) and Micrococcus tetragenus (M. tetragenus).The PQTs produced stronger antibacterial activity to E. coli than that to M. tetragenus through disrupting bacterial cell wall integrity. The antibacterial ratio was increased with the increasing dosages and incubation time. Next, we tested the in vivo antibacterial activity in mice. No noticeable organ damage was captured from H&E-staining organ slices, suggesting the promise of using PQTs for in vivo applications. The results of this study demonstrated the interaction between bacteria and PLGA-based nanoparticles, providing encouragement for conducting further investigations on properties and antimicrobial activity of the PQTs in clinical application.
Similar content being viewed by others
References
Abraham MH, Acree WE (2014) On the Solubility of Quercetin. J Mol Liq 1979:157–159
Alonso A et al (2013) Superparamagnetic Ag@Co-nanocomposites on granulated cation exchange polymeric matrices with enhanced antibacterial activity for the environmentally safe purification of water. Adv Funct Mater 2319:2450–2458
Andrews JM (2001) Determination of minimum inhibitory concentrations. J Antimicrob Chemoth 48(1):5–16
Applerot G, Lipovsky A, Dror R et al (2009) Enhanced antibacterial activity of nanocrystalline ZnO due to increased ROS-mediated cell injury. Adv Funct Mater 196:842–852
Bai X, Li L, Liu H et al (2015) Solvothermal synthesis of ZnO nanoparticles and anti-infection application in vivo. Acs Appl Mater Inter 72:1308–1317
Bala I, Hariharan S, Kumar MN (2004) PLGA nanoparticles in drug delivery: the state of the art. Crit Rev Ther Drug Carrier Syst 2121:387–422
Bindhu MR, Umadevi M (2014) Silver and gold nanoparticles for sensor and antibacterial applications. Spectrochim Acta A 12814:37–45
Chaudhury K et al (2014) Regenerative nanomedicine: current perspectives and future directions. Int J Nanomed 931:4153–4167
Cheng KK, Yeung CF, Ho SH et al (2013) Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer’s disease Tg2576 mice. Aaps J 152:324–336
Cornard JP, Merlin JC (2002) Spectroscopic and structural study of complexes of quercetin with Al(III). J Inorg Biochem 921:19–27
Danhier F, Ansorena E, Silva JM et al (2012) PLGA-based nanoparticles: an overview of biomedical applications. J Control Release 1612:505–522
Davoudi ZM, Kandjani AE et al (2014) Hybrid antibacterial fabrics with extremely high aspect ratio Ag/AgTCNQ nanowires. Adv Funct Mater 248:1047–1053
Dehghan G, Khoshkam Z (2012) Tin(II)–quercetin complex:synthesis, spectral characterisation and antioxidant activity. Food Chem 1312:422–426
Doiron AL, Homan KA, Emelianov S et al (2008) Poly(lactic-co-glycolic) acid as a carrier for imaging contrast agents. Pharm Res-Dordr 263:674–682
Faisant N, Akiki J, Siepmann F et al (2006) Effects of the type of release medium on drug release from PLGA-based microparticles: experiment and theory. Int J Pharm 3142:189–197
Fei Y, Xue Q et al (2006) Manufacturing and morphology structure of polylactide-type microtubules orientation-structured scaffolds. Biomaterials 2728:4923–4933
Ghosh S, Saraswathi A, Indi SS et al (2012) Ag@AgI, Core@shell structure in agarose matrix as hybrid: synthesis, characterization, and antimicrobial activity. Langmuir 2822:8550–8561
Hassan CM, Peppas NA (2000) Structure and morphology of freeze/thawed PVA hydrogels. Macromolecules 337:2000
Hoppens MA, Sylvester CB, Qureshi AT et al (2014) Ceragenin mediated selectivity of antimicrobial silver nanoparticles. Acs Appl Mater Inter 616:13900–13908
Ji Z, Wang X et al (2012) Designed synthesis of CeO2 nanorods and nanowires for studying toxicological effects of high aspect ratio nanomaterials. ACS Nano 66:5366–5380
Kamaly N et al (2012) Targeted polymeric therapeutic nanoparticles: design, development and clinical translation. Chem Soc Rev 417:2971–3010
Kocbek P et al (2007) Targeting cancer cells using PLGA nanoparticles surface modified with monoclonal antibody. J Control Release 1201–2:18–26
Lekshmi UMD, Poovi G, Kishore N et al (2010) In vitro characterization and in vivo toxicity study of repaglinide loaded poly (methyl methacrylate) nanoparticles. Int J Pharm 396:194–203
Li LL, Wang H (2013) Enzyme-coated mesoporous silica nanoparticles as efficient antibacterial agents in vivo. Adv Healthc Mater 210:1351–1360
Li Y, Zhang W et al (2012) Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles. ACS Nano 66:5164–5173
Macias CE, Bodugoz-Senturk H, Muratoglu OK (2013) Quantification of PVA hydrogel dissolution in water and bovine serum. Polymer 54:724–729
Mahmoudi M, Laurent S, Shokrgozar MA, Hosseinkhani M (2011) Toxicity evaluations of superparamagnetic iron oxide nanoparticles: cell “vision” versus physicochemical properties of nanoparticles. ACS Nano 59:7263–7276
Martínez JL (2008) Antibiotics and antibiotic resistance genes in natural environments. Science 3215887:365–367
Minardi S, Pandolfi L, Taraballi F et al (2015) PLGA-mesoporous silicon microspheres for the in vivo controlled temporo-spatial delivery of proteins. Acs Appl Mater Inter 730:16364–16373
Mosqueira VCF, Legrand P, Morgat JL et al (2001) Biodistribution of long-circulating PEG-grafted nanocapsules in mice: effects of PEG chain length and density. Pharm Res-Dordr 1810:1411–14199
Nurunnabi MD, Khatun Z, Kang MH et al (2013) In vivo biodistribution and toxicology of carboxylated graphene quantum dots. ACS Nano 78:6858–6867
Parveen S, Misra R, Sahoo SK (2012) Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging. Nanomed-Nanotechnol 82:147–166
Ravichandran R, Rajendran M, Devapiriam D (2014) Antioxidant study of quercetin and their metal complex and determination of stability constant by spectrophotometry method. Food Chem 1463:472–478
Seil JT, Tj Webster (2012) Antimicrobial applications of nanotechnology: methods and literature. Int J Nanomed 71:2767–2781
Shibata-Seki T, Tajima K, Takahashi H et al (2015) AFM characterization of chemically treated corneal cells. Anal Bioanal Chem 407:2631–2635
Sophie L, Carmen B et al (2012) Crucial ignored parameters on nanotoxicology: the importance of toxicity assay modifications and “cell vision”. Plos One 71:e29997
Stevanović M, Uskoković V, Filipović M, Škapin SD, Uskoković D et al (2013) Composite PLGA/AgNpPGA/AscH nanospheres with combined osteoinductive, antioxidative, and antimicrobial activities. Acs Appl Mater Inter 518:9034–9042
Tan H et al (2009) Gelatin/chitosan/hyaluronan scaffold integrated with PLGA microspheres for cartilage tissue engineering. Acta Biomater 51:328–337
Tang J et al (2013) Graphene oxide-silver nanocomposite as a highly effective antibacterial agent with species-specific mechanisms. Acs Appl Mater Inter 59:3867–3874
Tian T et al (2014) Graphene-based nanocomposite as an effective, multifunctional and recyclable antibacterial agent. Acs Appl Mater Inter 6:8542–8548
Vandervoort J, Ludwig A (2007) Ocular drug delivery: nanomedicine applications. Nanomedicine 21:11–21
Wischke C, Schwendeman SP (2008) Principles of encapsulating hydrophobic drugs in PLA/PLGA microparticles. Int J Pharm 3642:298–327
Xie SY, Wang SL et al (2008) Effect of PLGA as a polymeric emulsifier on preparation of hydrophilic protein-loaded solid lipid nanoparticles. J Control Release 672:199–204
Zhou J et al (2014) Construction and evaluation of Fe3O4-based PLGA nanoparticles carrying rtPA Used in the detection of thrombosis and in targeted thrombolysis. Acs Appl Mater Inter 68:5566–5576
Acknowledgments
The authors gratefully acknowledge the financial supports from the National Natural Science Foundation of China (21401002); the Natural Science Foundation of Anhui Province, China (1508085QB37); the Youth Science Found Key Project of Anhui Agricultural University (2013zr011); the Science Foundation of Young Teachers of Anhui Agricultural University (ZHSJ2013057); and the New Specialty of Biopharmaceutical Construction of Anhui Agricultural University (SJJD201313).
Author information
Authors and Affiliations
Corresponding author
Additional information
Dongdong Sun and Nuan Li have contributed equally to this work.
Rights and permissions
About this article
Cite this article
Sun, D., Li, N., Zhang, W. et al. Quercetin-loaded PLGA nanoparticles: a highly effective antibacterial agent in vitro and anti-infection application in vivo. J Nanopart Res 18, 3 (2016). https://doi.org/10.1007/s11051-015-3310-0
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s11051-015-3310-0